It's important to stay connected with everyone who is active in the field of regulatory science. Follow our regulatory science page and join our group on LinkedIn. And: don't forget to subscribe to science-related news on the MEB website.
Would you like to stay informed about our news updates, upcoming editions of the Regulatory Science Magazine or future events like the MEB Science Day?
Please subscribe to the news service on our website.
Just leave your mail address and select the frequency you would like to be informed!
LinkedIn is a social platform for professional networks. We've recently started our own showcase page to share updates on regulatory science research related to the work of the Dutch Medicines Evaluation Board (MEB).
At the MEB, we have a Science Policy that describes the strategic direction of our scientific focus in the period 2020 - 2024. Within the framework of this science policy we have adopted 8 main themes to focus on during these years. The themes are linked to developments in society, such as the replacement, reduction and refinement of animal testing, personalised medicine and the influence of big data on the assessment of medicines. Many of the themes are relevant for the development of medicines both for humans and for animals.
Please feel welcome to contribute to the discussion by commenting on the posts on the regulatory science LinkedIn page.
Do you want to share your own research with the regulatory science community? Join our RegScience group. So join in and share your scientific articles, read interviews with researchers or discuss all kinds of Regulatory Science insights. And feel free to invite your colleagues!
The group and LinkedIn page are managed by the Medicines Evaluation Board. The working language is English.